Value of serum human epidermal growth factor receptor 2 (HER2)/neu testing for early prediction of response to HER2/neu-directed therapies is still an open one and deserves further study in large prospective trials.

Source:http://linkedlifedata.com/resource/pubmed/id/19917836

J. Clin. Oncol. 2009 Dec 20 27 36 e273; author reply e274-5

Download in:

View as

General Info

PMID
19917836